APH vs TXMD · P/E 40, rev $23.09B vs rev $1.8M
Amphenol Corporation (APH) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the APH and TXMD stock pages for the full models.
Not investment advice.